These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 8478043)
21. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. J Clin Epidemiol; 1988; 41(12):1197-208. PubMed ID: 2905387 [TBL] [Abstract][Full Text] [Related]
22. An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril. Leonetti G; Trimarco B; Collatina S; Tosetti A Am J Hypertens; 1997 Oct; 10(10 Pt 2):230S-235S. PubMed ID: 9366278 [TBL] [Abstract][Full Text] [Related]
23. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679 [TBL] [Abstract][Full Text] [Related]
24. Isolated systolic hypertension: a new challenge in medicine. Sulbarán TA; Silva ER; Maestre G J Hum Hypertens; 2002 Mar; 16 Suppl 1():S44-7. PubMed ID: 11986893 [TBL] [Abstract][Full Text] [Related]
25. Isolated systolic hypertension in the elderly. Borhani NO J Hypertens Suppl; 1988 Nov; 6(1):S15-9. PubMed ID: 3063788 [TBL] [Abstract][Full Text] [Related]
27. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Kizer JR; Dahlöf B; Kjeldsen SE; Julius S; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Wachtell K; Edelman JM; Snapinn SM; Harris KE; Devereux RB Hypertension; 2005 Jan; 45(1):46-52. PubMed ID: 15583076 [TBL] [Abstract][Full Text] [Related]
28. Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program. Kostis WJ; Sargsyan D; Mekkaoui C; Moreyra AE; Cabrera J; Cosgrove NM; Sedjro JE; Kostis JB; Cushman WC; Pantazopoulos JS; Pressel SL; Davis BR J Hum Hypertens; 2019 Oct; 33(10):735-740. PubMed ID: 30804464 [TBL] [Abstract][Full Text] [Related]
29. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A; J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316 [TBL] [Abstract][Full Text] [Related]
30. Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension. Maxwell MH; Garrett BN; Saunders E; Schnaper H Clin Ther; 1987; 9(4):380-9. PubMed ID: 3607820 [TBL] [Abstract][Full Text] [Related]
31. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176 [TBL] [Abstract][Full Text] [Related]
32. Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project. Siegel D; Kuller L; Lazarus NB; Black D; Feigal D; Hughes G; Schoenberger JA; Hulley SB Am J Epidemiol; 1987 Sep; 126(3):385-99. PubMed ID: 3303916 [TBL] [Abstract][Full Text] [Related]
33. Association between chlorthalidone treatment of systolic hypertension and long-term survival. Kostis JB; Cabrera J; Cheng JQ; Cosgrove NM; Deng Y; Pressel SL; Davis BR JAMA; 2011 Dec; 306(23):2588-93. PubMed ID: 22187278 [TBL] [Abstract][Full Text] [Related]
34. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358 [TBL] [Abstract][Full Text] [Related]
36. Treating isolated systolic hypertension in the elderly. Howard PA Ann Pharmacother; 1994 Mar; 28(3):367-73. PubMed ID: 8193428 [TBL] [Abstract][Full Text] [Related]
37. The role of diastolic blood pressure when treating isolated systolic hypertension. Somes GW; Pahor M; Shorr RI; Cushman WC; Applegate WB Arch Intern Med; 1999 Sep; 159(17):2004-9. PubMed ID: 10510985 [TBL] [Abstract][Full Text] [Related]
38. [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle]. Chieppa S; Lobascio C; Brandini V; Iarussi D; Giuliani F; Langella S; De Simone R Cardiologia; 1989 Aug; 34(8):695-9. PubMed ID: 2605580 [TBL] [Abstract][Full Text] [Related]
39. [Hypertension as a function of age]. Gensini GF; Corradi F Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125 [TBL] [Abstract][Full Text] [Related]